Si Bone, Inc. SIBN
We take great care to ensure that the data presented and summarized in this overview for SI-BONE, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIBN
View all-
Black Rock Inc. New York, NY3.85MShares$52.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.44MShares$47 Million1.31% of portfolio
-
Brown Advisory Inc3.19MShares$43.5 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.72MShares$37.1 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$32.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$32.5 Million0.02% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.95MShares$26.7 Million0.19% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$22.3 Million1.08% of portfolio
-
Paradigm Capital Management Inc1.32MShares$18 Million0.83% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.26MShares$17.3 Million0.01% of portfolio
Latest Institutional Activity in SIBN
Top Purchases
Top Sells
About SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Insider Transactions at SIBN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 02
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,311
-0.61%
|
$46,354
$14.12 P/Share
|
|
Apr 02
2025
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,311
-0.58%
|
$46,354
$14.15 P/Share
|
|
Apr 02
2025
|
Michael A Pisetsky SVP, Ops & Adm/Chief Legal Ofr |
SELL
Open market or private sale
|
Direct |
3,128
-0.42%
|
$43,792
$14.04 P/Share
|
|
Feb 18
2025
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
1,619
-9.63%
|
$25,904
$16.77 P/Share
|
|
Feb 18
2025
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
9,531
-0.54%
|
$152,496
$16.82 P/Share
|
|
Feb 18
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,180
-0.57%
|
$178,880
$16.94 P/Share
|
|
Feb 18
2025
|
Laura Francis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
46,233
-0.79%
|
$785,961
$17.03 P/Share
|
|
Feb 03
2025
|
Anshul Maheshwari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,465
+14.63%
|
-
|
|
Feb 03
2025
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
337
-1.91%
|
$5,392
$16.51 P/Share
|
|
Feb 03
2025
|
Laura Francis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
244,630
+14.1%
|
-
|
|
Feb 03
2025
|
Anthony J Recupero President, Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
74,583
+11.31%
|
-
|
|
Jan 02
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,304
-0.92%
|
$68,952
$13.91 P/Share
|
|
Jan 02
2025
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,670
-0.81%
|
$47,710
$13.9 P/Share
|
|
Nov 19
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
2,070
-0.91%
|
$24,840
$12.17 P/Share
|
|
Nov 18
2024
|
Laura Francis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,048
-0.41%
|
$120,576
$12.59 P/Share
|
|
Nov 18
2024
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,439
-0.62%
|
$29,268
$12.69 P/Share
|
|
Nov 18
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,937
-0.57%
|
$47,244
$12.7 P/Share
|
|
Nov 18
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
1,609
-7.3%
|
$19,308
$12.43 P/Share
|
|
Nov 04
2024
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
341
-1.52%
|
$4,433
$13.55 P/Share
|
|
Oct 03
2024
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
921
-0.39%
|
$11,973
$13.6 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 496K shares |
|---|---|
| Exercise of conversion of derivative security | 68.7K shares |
| Open market or private sale | 155K shares |
|---|